vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and McEwen Inc. (MUX). Click either name above to swap in a different company.

McEwen Inc. is the larger business by last-quarter revenue ($64.6M vs $45.5M, roughly 1.4× Cryoport, Inc.). McEwen Inc. runs the higher net margin — 59.0% vs -17.5%, a 76.5% gap on every dollar of revenue. On growth, McEwen Inc. posted the faster year-over-year revenue change (92.8% vs 9.6%). Over the past eight quarters, McEwen Inc.'s revenue compounded faster (25.2% CAGR vs 10.4%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

McEwen Inc (ticker MUX) is a natural resource company primarily engaged in the exploration, development, and production of gold, silver, and copper assets. Its core operations are located across North and South America, serving global commodity markets with a focus on sustainable, responsible mining practices.

CYRX vs MUX — Head-to-Head

Bigger by revenue
MUX
MUX
1.4× larger
MUX
$64.6M
$45.5M
CYRX
Growing faster (revenue YoY)
MUX
MUX
+83.1% gap
MUX
92.8%
9.6%
CYRX
Higher net margin
MUX
MUX
76.5% more per $
MUX
59.0%
-17.5%
CYRX
Faster 2-yr revenue CAGR
MUX
MUX
Annualised
MUX
25.2%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYRX
CYRX
MUX
MUX
Revenue
$45.5M
$64.6M
Net Profit
$-8.0M
$38.1M
Gross Margin
47.8%
26.9%
Operating Margin
-17.0%
34.2%
Net Margin
-17.5%
59.0%
Revenue YoY
9.6%
92.8%
Net Profit YoY
57.4%
563.1%
EPS (diluted)
$-0.19
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
MUX
MUX
Q4 25
$45.5M
$64.6M
Q3 25
$44.2M
$50.5M
Q2 25
$45.5M
$46.7M
Q1 25
$41.0M
$35.7M
Q4 24
$41.5M
$33.5M
Q3 24
$38.3M
$52.3M
Q2 24
$39.7M
$47.5M
Q1 24
$37.3M
$41.2M
Net Profit
CYRX
CYRX
MUX
MUX
Q4 25
$-8.0M
$38.1M
Q3 25
$-6.9M
$-462.0K
Q2 25
$105.2M
$3.0M
Q1 25
$-12.0M
$-6.3M
Q4 24
$-18.7M
$-8.2M
Q3 24
$805.0K
$-2.1M
Q2 24
$-78.0M
$-13.0M
Q1 24
$-18.9M
$-20.4M
Gross Margin
CYRX
CYRX
MUX
MUX
Q4 25
47.8%
26.9%
Q3 25
48.2%
15.5%
Q2 25
47.0%
26.3%
Q1 25
45.4%
28.2%
Q4 24
47.0%
1.1%
Q3 24
45.5%
26.4%
Q2 24
44.5%
22.7%
Q1 24
40.4%
14.6%
Operating Margin
CYRX
CYRX
MUX
MUX
Q4 25
-17.0%
34.2%
Q3 25
-22.5%
-16.7%
Q2 25
-21.2%
-7.2%
Q1 25
-23.1%
-21.4%
Q4 24
-30.7%
-43.4%
Q3 24
-34.9%
-0.2%
Q2 24
-196.5%
-29.4%
Q1 24
-46.9%
-53.3%
Net Margin
CYRX
CYRX
MUX
MUX
Q4 25
-17.5%
59.0%
Q3 25
-15.7%
-0.9%
Q2 25
231.4%
6.5%
Q1 25
-29.2%
-17.6%
Q4 24
-45.1%
-24.6%
Q3 24
2.1%
-4.0%
Q2 24
-196.4%
-27.4%
Q1 24
-50.7%
-49.4%
EPS (diluted)
CYRX
CYRX
MUX
MUX
Q4 25
$-0.19
$0.66
Q3 25
$-0.18
$-0.01
Q2 25
$2.05
$0.06
Q1 25
$-0.28
$-0.12
Q4 24
$-0.42
$-0.15
Q3 24
$-0.02
$-0.04
Q2 24
$-1.62
$-0.26
Q1 24
$-0.43
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
MUX
MUX
Cash + ST InvestmentsLiquidity on hand
$411.2M
$72.1M
Total DebtLower is stronger
$126.2M
Stockholders' EquityBook value
$502.6M
$546.2M
Total Assets
$765.0M
$820.2M
Debt / EquityLower = less leverage
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
MUX
MUX
Q4 25
$411.2M
$72.1M
Q3 25
$421.3M
$75.4M
Q2 25
$426.0M
$69.5M
Q1 25
$244.0M
$79.3M
Q4 24
$250.6M
$15.3M
Q3 24
$259.4M
$30.2M
Q2 24
$414.9M
$42.6M
Q1 24
$438.2M
$22.0M
Total Debt
CYRX
CYRX
MUX
MUX
Q4 25
$126.2M
Q3 25
$126.0M
Q2 25
$125.8M
Q1 25
$125.5M
Q4 24
$40.0M
Q3 24
$31.0M
Q2 24
$34.0M
Q1 24
$37.0M
Stockholders' Equity
CYRX
CYRX
MUX
MUX
Q4 25
$502.6M
$546.2M
Q3 25
$513.3M
$488.6M
Q2 25
$519.1M
$484.5M
Q1 25
$398.8M
$479.8M
Q4 24
$401.9M
$495.0M
Q3 24
$418.6M
$502.1M
Q2 24
$400.1M
$485.2M
Q1 24
$472.2M
$482.5M
Total Assets
CYRX
CYRX
MUX
MUX
Q4 25
$765.0M
$820.2M
Q3 25
$774.3M
$747.6M
Q2 25
$773.9M
$735.6M
Q1 25
$699.8M
$730.6M
Q4 24
$703.5M
$664.6M
Q3 24
$701.8M
$667.8M
Q2 24
$852.3M
$645.1M
Q1 24
$942.8M
$638.7M
Debt / Equity
CYRX
CYRX
MUX
MUX
Q4 25
0.23×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.26×
Q4 24
0.08×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
MUX
MUX
Operating Cash FlowLast quarter
$919.0K
$3.1M
Free Cash FlowOCF − Capex
$-4.5M
FCF MarginFCF / Revenue
-10.0%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
MUX
MUX
Q4 25
$919.0K
$3.1M
Q3 25
$2.2M
$5.2M
Q2 25
$-7.3M
$478.0K
Q1 25
$-4.3M
$-1.9M
Q4 24
$-5.5M
$-1.2M
Q3 24
$447.0K
$23.2M
Q2 24
$-8.0M
$3.6M
Q1 24
$-3.3M
$3.9M
Free Cash Flow
CYRX
CYRX
MUX
MUX
Q4 25
$-4.5M
Q3 25
$-1.3M
Q2 25
$-11.7M
Q1 25
$-7.5M
Q4 24
$-10.7M
Q3 24
$-3.8M
Q2 24
$-11.8M
Q1 24
$-7.3M
FCF Margin
CYRX
CYRX
MUX
MUX
Q4 25
-10.0%
Q3 25
-2.9%
Q2 25
-25.7%
Q1 25
-18.3%
Q4 24
-25.8%
Q3 24
-9.9%
Q2 24
-29.8%
Q1 24
-19.5%
Capex Intensity
CYRX
CYRX
MUX
MUX
Q4 25
12.0%
Q3 25
7.8%
Q2 25
9.6%
Q1 25
7.7%
Q4 24
12.6%
Q3 24
11.1%
Q2 24
9.5%
Q1 24
10.7%
Cash Conversion
CYRX
CYRX
MUX
MUX
Q4 25
0.08×
Q3 25
Q2 25
-0.07×
0.16×
Q1 25
Q4 24
Q3 24
0.56×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons